(Q34761446)

4 August 2017

1 reference

title

Sexual dysfunction in schizophrenia: focus on recent evidence (English)

1 reference

4 August 2017

0 references

1 reference

Martin Baggaley

1

1 reference

4 August 2017

1 April 2008

1 reference

4 August 2017

Human Psychopharmacology

1 reference

4 August 2017

23

1 reference

4 August 2017

3

1 reference

4 August 2017

201-209

1 reference

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

4 August 2017

1 reference

Sexuality and schizophrenia: a review

21 January 2018

1 reference

Sexual dysfunction associated with neuroleptic-induced hyperprolactinemia improves with reduction in prolactin levels

21 January 2018

1 reference

7 January 2021

Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine

1 reference

7 January 2021

Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report.

1 reference

7 January 2021

A new atypical antipsychotic: quetiapine-induced sexual dysfunctions

1 reference

7 January 2021

An open-label trial of sildenafil addition in risperidone-treated male schizophrenia patients with erectile dysfunction.

1 reference

7 January 2021

Antipsychotic treatment and sexual functioning in first-time neuroleptic-treated schizophrenic patients

1 reference

7 January 2021

Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol: the results of the EIRE study

1 reference

7 January 2021

An open-label trial of quetiapine for antipsychotic-induced sexual dysfunction.

1 reference

7 January 2021

An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder.

1 reference

7 January 2021

A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia

1 reference

7 January 2021

Sexual dysfunction and antipsychotic treatment

1 reference

7 January 2021

Prevalence of sexual dysfunction in patients with schizophrenia: international variation and underestimation.

1 reference

7 January 2021

Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.

1 reference

7 January 2021

Subjective utility ratings of neuroleptics in treating schizophrenia

1 reference

7 January 2021

Sildenafil in the treatment of antipsychotic-induced erectile dysfunction: a randomized, double-blind, placebo-controlled, flexible-dose, two-way crossover trial

1 reference

7 January 2021

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management

1 reference

7 January 2021

Hyperprolactinaemia and antipsychotic therapy in schizophrenia

1 reference

7 January 2021

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

1 reference

7 January 2021

Evaluating sexual function in patients with treatment-resistant schizophrenia

1 reference

7 January 2021

A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia

1 reference

7 January 2021

Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone

1 reference

7 January 2021

Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine

1 reference

7 January 2021

What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?

1 reference

7 January 2021

A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning

1 reference

7 January 2021

A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning

1 reference

7 January 2021

Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence

1 reference

7 January 2021

Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study.

1 reference

7 January 2021

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

7 January 2021

Nithsdale Schizophrenia Surveys 24: sexual dysfunction. Case-control study

1 reference

7 January 2021

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

1 reference

7 January 2021

The Arizona Sexual Experience Scale (ASEX): reliability and validity

1 reference

7 January 2021

Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia

1 reference

7 January 2021

1 reference

7 January 2021

A 6-month prospective observational study on the effects of quetiapine on sexual functioning

1 reference

7 January 2021

Male sexual dysfunction and quality of life in schizophrenia.

1 reference

7 January 2021

Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.

1 reference

7 January 2021

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

7 January 2021

Healthy aging and male sexual function

1 reference

7 January 2021

Sexual dysfunction in patients taking conventional antipsychotic medication

1 reference

7 January 2021

Prolactin levels and erectile function in patients treated with risperidone

1 reference

7 January 2021

Comparison between risperidone, olanzapine, and clozapine in the management of chronic schizophrenia: a naturalistic prospective 12-week observational study.

1 reference

7 January 2021

Sexual dysfunction in major depression.

1 reference

7 January 2021

Prevalence of sexual dysfunction in three psychiatric outpatient settings: A drug misuse service, an alcohol misuse service and a general adult psychiatry clinic

1 reference

7 January 2021

Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration.

1 reference

7 January 2021

Identifiers

DOI

10.1002/HUP.924

1 reference

release_cz2lrpt6gnegzppagsxfqbmvci

4 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cz2lrpt6gnegzppagsxfqbmvci

24 November 2022

mapped directly with Wikidata item

PubMed ID

18338766

1 reference

PubMed ID

18338766